Aethlon Medical, Inc. (AEMD) Fair Value 2026

AEMD · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.7 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (46/100)

Quick Summary — As of 2026-08-27, Aethlon Medical, Inc. (AEMD) trades at $2.17. QOC: 4.7/10. Value Trap Risk: 46/100 (WARN). 0/13 models active.

Key Facts

Ticker
AEMD
Price
$2.17
Quality Score
4.7/10
Value Trap Risk
46/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 46 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give AEMD?

0 Intrinsic Value Models vs. Current Price ($2.17)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Aethlon Medical, Inc. (AEMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Aethlon Medical, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About AEMD?

0 of 13 models are currently active for AEMD. See which stocks rank higher →

How Does AEMD Rank in Medical Devices?

Among 157 Medical Devices stocks, AEMD ranks #130 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

As a pharmaceutical industry, Aethlon Medical, Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating AEMD should weigh these sector-specific dynamics alongside our model-derived fair values.

Is AEMD a Value Trap?

CirclFi's Value Trap algorithm assigns AEMD a score of 46/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Aethlon Medical, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Aethlon Medical, Inc.'s fundamental quality profile registers 4.7/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AEMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Aethlon Medical, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ALURAllurion Technologies Inc.QOC 4.8RMSLREMSleep Holdings, Inc.QOC 4.6TRIBTrinity Biotech plcQOC 4.8PAVMPAVmed Inc.QOC 4.6FEEDENvue Medical, Inc.QOC 4.8RBOTVicarious Surgical Inc.QOC 4.6ABTAbbott LaboratoriesQOC 8.8PRCTPROCEPT BioRobotics CorporationQOC 6.9VYCOVycor Medical, Inc.QOC 6.0IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ALUR · RMSL · TRIB · PAVM · FEED · RBOT · ABT · PRCT · VYCO · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to AEMD?

7 companies across all industries closest to AEMD’s Quality of Company score of 4.7/10.

SHMDSCHMID Group N.V.QOC 4.7CBLOC2 Blockchain, Inc.QOC 4.7ERASErasca, Inc.QOC 4.7BKTBlackRock Income Trust, Inc.QOC 4.7SPPLSimpple Ltd.QOC 4.7SYBXSynlogic, Inc.QOC 4.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SHMD · CBLO · ERAS · BKT · SPPL · SYBX · NVDA

Where Does AEMD Sit in CirclFi's Medical Devices Rankings?

AEMD is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Aethlon Medical, Inc.’s Valuation?

What is Aethlon Medical, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Aethlon Medical, Inc. (AEMD). The Quality of Company score is 4.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AEMD overvalued or undervalued right now?

At $2.17, 0 of 0 active models suggest AEMD may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Aethlon Medical, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 4.7 mean for AEMD?

Aethlon Medical, Inc.'s QOC of 4.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on AEMD?

CirclFi analyzes AEMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is AEMD a value trap in 2026?

Aethlon Medical, Inc.'s Value Trap score is 46/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Aethlon Medical, Inc. (AEMD) a Quality of Company score of 4.7/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/AEMD/ · Methodology
Primary sources for this AEMD valuation
  • Financial statements: Aethlon Medical, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000882291) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for AEMD as of ; valuations recomputed .